AHA Coding Clinic® for HCPCS - 2016 Issue 4; For Your Information

Drugs and Biologicals with OPPS Pass-Through Status

As of October 1, 2016, these four drugs and biologicals were granted outpatient prospective payment system (OPPS) pass-through status. The HCPCS codes for the drug and biologicals in addition to their long descriptor are listed below. HCPCS CodeLong Descriptor* C9139 Injection, Factor IX, albumin fusion protein (recombinant), Idelvion, 1 i.u. * C9481 Injection, reslizumab, 1 mg * C9482 Injection, sotalol hydrochloride, 1 mg * C9483 Injection, atezolizumab, 10 mg * Please note HCPCS codes C9139 and C9481 will be replaced by HCPCS J codes, effective January 1, 2017. The HCPCS J codes are listed in the table below...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.